52427-815 : GraliseGralise Kit


NDC52427-815
Labeler: Almatica Pharma LLC
Product Type: Human Prescription Drug
Drug Name:  Gralise
Dosage Form: Kit
Application #: NDA022544
Rev. Date: 


NDC Package Codes:

  • 52427-815-99: 1 KIT IN 1 BLISTER PACK (52427‑815‑99)

Related Products:

Based on records with the same trade name.
  • 52427-803 Gralise 300 mg Oral Tablet, Film Coated by Almatica Pharma LLC
  • 52427-804 Gralise 450 mg Oral Tablet, Film Coated by Almatica Pharma LLC
  • 52427-806 Gralise 600 mg Oral Tablet, Film Coated by Almatica Pharma LLC
  • 52427-850 Gralise 750 mg Oral Tablet, Film Coated by Almatica Pharma LLC
  • 52427-890 Gralise 900 mg Oral Tablet, Film Coated by Almatica Pharma LLC
  • 13913-004 Gralise 300 mg Oral Tablet by Depomed, Inc.
  • 13913-005 Gralise 600 mg Oral Tablet by Depomed, Inc.
  • 13913-006 Gralise Starter Pack by Depomed, Inc.
  • 50436-1262 Gralise 600 mg Oral Tablet, Film Coated by Unit Dose Services
  • 63629-5052 Gralise 600 mg Oral Tablet, Film Coated by Bryant Ranch Prepack

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 52427-815 QR Code

< Prev: 52427-809Next: 52427-816 >

Related Discussions:

gralise medication
Please use extreme caution when using this drug. My husband is a chronic pain sufferer. His pain doc prescribed it for h... 4 replies
Gralise (gabapentin) Reviews
I tapered up to 1800 mg on a sample pack and my Dr. didn't listen & called in Gabapentin. I tried that off &... 3 replies
Taking Gralise for Trigeminal Neuralgia
I take Gralise for Trigeminal Neuralgia, TN2 (1800 mg). It works far better then Gabapentin, which made me feel terrible...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.